Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers Squibb

Executive Summary

William Comer, PhD, appointed to senior VP-strategic management of Bristol-Myers Squibb Pharmaceutical Group with responsibility for worldwide licensing, strategic product planning and commercial development. Prior to his new appointment, Comer was president of Bristol-Myers Pharmaceutical Research and the Bristol-Myers Squibb Licensing Group, not president of Bristol-Myers Pharmaceutical Research & Development as reported in the March 29 "The Pink Sheet" (T&G-9). His responsibilities included Bristol-Myers Research & Development Division, Oncogen, and Bristol-Myers Squibb licensing functions. Among those reporting to Comer was Stephen Carter, MD, president of Bristol-Myers Pharmaceutical Research & Development Division since last September. Carter now reports to new Bristol-Myers Squibb Research Institute President Edgar Haber, MD.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017185

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel